Third Harmonic Bio Competitors and Similar CompaniesClear all

Third Harmonic Bio's competitors and similar companies include Cipla, Mankind Pharma and UCB.

	Third Harmonic Bio Third Harmonic Bio is a clinical-stage biopharmaceutical company focused on the development of medicine for the treatment of allergic and inflammatory diseases.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2019	Founding Date 1935	Founding Date 1995	Founding Date 1928
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Cambridge, US HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 16	Employees 27,764	Employees 16,2532% increase	Employees 9,052
Valuation ($)	Valuation ($) 599.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit N/A	Gross profit €7.2b (FY, 2025)
Net income	Net income ($45.5m) (FY, 2024)	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income €1.6b (FY, 2025)